[HTML][HTML] Risk of recurrent cancer-associated venous thromboembolism: A Danish nationwide cohort study
Background Predictive factors for recurrent cancer-associated venous thromboembolism
have been inconsistent across previous studies. To provide data for improved risk …
have been inconsistent across previous studies. To provide data for improved risk …
Emerging Biomarkers for Assessing Thrombotic Risk in Patients Receiving Direct Oral Anticoagulants (DOACs)
A Sabana M, A Simon M - Cardiovascular & Hematological …, 2024 - benthamdirect.com
Direct Oral Anticoagulants (DOACs) have transformed the management of thrombotic
disorders, offering a more convenient and effective alternative to traditional vitamin K …
disorders, offering a more convenient and effective alternative to traditional vitamin K …
Updated review on malignancy-associated venous thromboembolism: Pathogenesis and comparison between various therapeutic modalities
H Elmukhtar, H Ala, R Amnna, F Kalifa… - Yemen Journal of …, 2024 - yjomonline.com
Venous thromboembolism (VTE) is one of the life-threatening complications in cancer
patients, the incidence of which is affected by the patient and malignancy-related variables …
patients, the incidence of which is affected by the patient and malignancy-related variables …